Aberrant JAK2 fusion proteins have been characterized in hematological cancers like acute lymphocytic leukemia (ALL) [8], acute myeloid leukemia [9] often mediating constitutive STAT activation. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.